NCR Voyix Corp financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data NCR Voyix Corp files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	6,543	6,516	6,405	6,915	6,207	7,156	3,174	3,166	2,818	2,687
Cost of revenue	2,102	2,026
Gross profit	4,441	4,490
Research and development	225	241	252	259	234	195	116	139	157	155
Selling, general and administrative	904	923	1,005	1,051	1,069	704	618	658	458	453
Operating income	674	691	191	611	221	26	-50	-134	-38	26
Interest expense	170	163	168	197	218	238	285	294	134	60
Other non-operating income	-125	-46	16	-73	-42	-13	18	-75	-33	3
Pre-tax income	379	482	39	341	-59	-267	-317	-549	-197	-31
Income tax	92	242	73	-273	-53	70	52	184	4	-73
Income from continuing operations	283	237	-36	614	-7	-337	-369	-733	-201	42
Net income to minority interests	4	3	2	0	1	1	0	0	-1
Net income	270	232	-88	564	-79	97	60	-428	958	62
EBITDA	1,018	1,045	521	944	585	543	560	425	259	257
EPS, basic	1.88	1.08	-1.24	3.98	-0.92	0.62	0.32	-3.16	6.52	0.30
EPS, diluted	1.83	1.04	-1.24	3.59	-0.92	0.62	0.32	-3.16	6.52	0.30
Shares, basic (weighted)	117	114	111	114	120	131	137	141	145	139
Shares, diluted (weighted)	121	119	111	136	120	131	137	141	145	141

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	498	537	464	509	338	221	218	256	722	231
Receivables	1,282	1,270	1,356	1,490	1,117	959	550	414	532	470
Inventory	699	780	806	784	601	754	357	250	208	217
Other current assets	278	243	397	361	363	421	247	178	166	176
Total current assets	2,757	2,830	3,023	3,144	2,478	2,876	3,082	1,206	1,671	1,103
Property, plant and equipment	287	341	359	413	373	703	227	207	192	174
Lease right-of-use assets			0	391	344	419	272	231	229	208
Goodwill	2,727	2,741	2,692	2,832	2,837	4,519	2,064	1,519	1,516	1,520
Intangible assets	672	578	595	607	532	1,316	416	123	94	83
Other non-current assets	561	586	504	601	686	776	744	532	514	598
Total assets	7,673	7,654	7,761	8,987	8,414	11,641	11,507	4,990	4,452	3,921
Accounts payable	781	762	897	840	632	826	594	440	324	346
Accrued liabilities	234	219	238	308	268	389	87	126	104	97
Deferred revenue				502	507	516	191	157	209	199
Short-term debt	50	52	185	282	8	57	101	15	0	0
Total current liabilities	1,965	1,889	2,282	2,538	2,088	2,808	2,713	1,333	1,420	1,065
Long-term debt	3,001	2,939	2,980	3,277	3,270	5,505	5,552	2,563	1,098	1,100
Lease liabilities			0	369	325	388	286	251	248	226
Other non-current liabilities	138	200	259	240	334	383	185	253	241	156
Total liabilities	6,112	6,107	6,489	7,485	7,090	10,108	9,753	4,689	3,245	2,766
Total debt	3,080	3,014	3,183	3,591	3,318	5,622	5,714	2,578	1,105	1,105
Paid-in capital	32	60	34	312	368	515	704	874	866	827
Retained earnings	867	857	606	1,060	950	1,031	1,075	-421	535	559
Other comprehensive income	-205	-199	-246	-269	-271	-291	-300	-429	-469	-439
Shareholders' equity	695	719	395	1,104	1,048	1,256	1,480	25	933	948
Minority interests	4	3	4	3	3	3	-1	0	-2	0
Total equity	699	722	399	1,107	1,051	1,259	1,479	25	931	948
Total liabilities and equity	7,673	7,654	7,761	8,987	8,414	11,641	11,507	4,990	4,452	3,921
Shares outstanding	117	114	110	119	121	132	138	143	142	138

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	274	235	-86	564	-78	98	59	-428	957	62
Depreciation and amortization	344	354	330	333	364	517	610	559	297	231
Stock-based compensation	61	77	72	107	108	154	125	177	47	34
Deferred income tax	10	173	14	-355	-112	89	60	140	43	9
Change in inventory	-86	-68	-70	5	168	-195	-188	9	39	-26
Cash from operations	894	752	572	634	641	1,009	427	694	-132	-210
Capital expenditures	-73	-128	-143	-91	-31	-106	-92	-130	-30	-165
Acquisitions	0	-8	-160	-203	-25	-2,473	-13	-7	0	0
Purchases of investments							0	-10	0	0
Sales and maturities of investments			0	0	27	14	0	0
Cash from investing	-189	-290	-474	-512	-277	-2,826	-387	-290	2,189	-134
Share buybacks	-250	-350	-210	-96	-41	0	0	0	-56	-74
Cash from financing	-467	-434	-48	-61	-514	2,178	1	-839	-1,560	-175
Exchange rate effect	-29	16	-25	-6	-7	-18	-50	-20	-24	4
Net change in cash	172	36	-11	31	-157	343	-9	-455	473	-515
Free cash flow	821	624	429	543	610	903	335	564	-162	-375
Interest paid	155	159	160	168	196	215	268	365	145	57
Income taxes paid	66	98	106	61	82	42	56	92	54	316

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $6.83 on September 28, 2026.

Profitability

Metric	Value	How it is calculated
Operating margin	1.1%	Operating income / revenue.
EBITDA margin	9.7%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	-1.7%	Pre-tax income / revenue.
Net margin	3.0%	Net income / revenue.
Operating cash flow margin	5.2%	Cash from operations / revenue.
Return on equity (ROE)	8.2%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	2.0%	Net income / average total assets.
Return on invested capital (ROIC)	1.3%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	6.0%	Research and development expense / revenue.
SG&A / revenue	17.8%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	1.4%	Stock-based compensation (from the cash flow statement) / revenue.
D&A / revenue	8.6%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-4.6%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-5.4%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	-15.4%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income CAGR, 5y	-34.8%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	-0.8%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-22.9%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	-15.2%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-93.5%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	1.1%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS growth, 1y	-95.4%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-2.1%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value growth, 1y	1.6%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-13.8%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	-2.0%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-11.9%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-30.2%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-14.2%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-2.5%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	1.1%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	3.3%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.07x	Current assets / current liabilities.
Quick ratio	0.66x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.23x	(Cash + short-term investments) / current liabilities.
Debt / equity	1.19x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	28.6%	Total debt / total assets.
Liabilities / assets	70.6%	Total liabilities / total assets.
Net debt	$864.0M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	3.48x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	0.48x	Operating income / interest expense.
Working capital	$75.0M	Current assets - current liabilities.
Goodwill and intangibles / assets	41.3%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$663.0M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.66x	Revenue / average total assets.
Fixed asset turnover	15.1x	Revenue / average property, plant and equipment.
Receivables turnover	5.63x	Revenue / average receivables.
Days sales outstanding	65 days	365 x average receivables / revenue.

Per share

Metric	Value	How it is calculated
EPS, diluted	$0.55	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$18.46	Revenue / diluted weighted shares.
Operating cash flow per share	$0.97	Cash from operations / diluted weighted shares.
Book value per share	$6.73	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$4.82	Tangible book value / shares outstanding.
Cash per share	$1.72	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$943.0M	Share price x shares outstanding.
Enterprise value	$1.81B	Market cap + total debt - cash - short-term investments.
P/E	12.4x	Market cap / net income. Only when net income is positive.
P/S	0.37x	Market cap / revenue.
P/B	1.02x	Market cap / shareholders' equity. Only when equity is positive.
P/OCF	7.09x	Market cap / cash from operations, when positive.
EV/Sales	0.71x	Enterprise value / revenue.
EV/EBIT	62.3x	Enterprise value / operating income, when both are positive.
EV/EBITDA	7.29x	Enterprise value / EBITDA, when both are positive.
Earnings yield	8.1%	Net income / market cap (the inverse of P/E).
Shareholder yield	2.7%	(Dividends paid + share buybacks) / market cap.

What was NCR Voyix Corp's revenue in fiscal 2025?

NCR Voyix Corp reported revenue of $2.69B for fiscal 2025, 4.6% lower than the year before.

Was NCR Voyix Corp profitable in fiscal 2025?

Yes. Net income was $62.0M, a net margin of 2.3%.

How much free cash flow did NCR Voyix Corp generate in fiscal 2025?

Cash from operations of $210.0M minus capital expenditures of $165.0M left free cash flow of -$375.0M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to NCR Voyix Corp